跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAPLE TOBRAMYCIN tobramycin 300mg/5mL solution for inhalation ampoules - TGA Drug Approval Details
Approvals
/
TGA
/
MAPLE TOBRAMYCIN tobramycin 300mg/5mL solution for inhalation ampoules
Approved
STANDARD
MAPLE TOBRAMYCIN tobramycin 300mg/5mL solution for inhalation ampoules
Maple Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e15a9a1ed9f701bd
Company
Maple Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
e15a9a1ed9f701bd
Product Name
MAPLE TOBRAMYCIN tobramycin 300mg/5mL solution for inhalation ampoules
Artg Id
279354
Artg Name
MAPLE TOBRAMYCIN tobramycin 300mg/5mL solution for inhalation ampoules
Sponsor
Maple Healthcare Pty Ltd
Company Detail Path
/organization/maple-healthcare-pty-ltd
Artg Date
2018-02-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e15a9a1ed9f701bd
Type
Standard
Back to TGA Approvals